Allworth Financial’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-100
| Closed | -$10K | – | 1155 |
|
|
2019
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 595 |
|
|
2019
Q2 | $9K | Hold |
100
| – | – | ﹤0.01% | 607 |
|
|
2019
Q1 | $9K | Sell |
100
-684
| -87% | -$59.8K | ﹤0.01% | 601 |
|
|
2018
Q4 | $50K | Buy |
784
+443
| +130% | +$32.7K | ﹤0.01% | 275 |
|
|
2018
Q3 | $31K | Hold |
341
| – | – | ﹤0.01% | 360 |
|
|
2018
Q2 | $27K | Buy |
341
+52
| +18% | +$4.32K | ﹤0.01% | 363 |
|
|
2018
Q1 | $26K | Sell |
289
-75
| -21% | -$7.2K | ﹤0.01% | 335 |
|
|
2017
Q4 | $38K | Buy |
364
+4
| +1% | +$451 | ﹤0.01% | 279 |
|
|
2017
Q3 | $52K | Buy |
360
+73
| +25% | +$9.94K | ﹤0.01% | 238 |
|
|
2017
Q2 | $37K | Hold |
287
| – | – | ﹤0.01% | 288 |
|
|
2017
Q1 | $36K | Buy |
287
+39
| +16% | +$4.67K | ﹤0.01% | 279 |
|
|
2016
Q4 | $29K | Hold |
248
| – | – | ﹤0.01% | 273 |
|
|
2016
Q3 | $26K | Sell |
248
-10
| -4% | -$1.08K | ﹤0.01% | 291 |
|
|
2016
Q2 | $25K | Buy |
258
+100
| +63% | +$10.3K | ﹤0.01% | 282 |
|
|
2016
Q1 | $16K | Hold |
158
| – | – | ﹤0.01% | 339 |
|
|
2015
Q4 | $19K | Sell |
158
-113
| -42% | -$13.1K | ﹤0.01% | 313 |
|
|
2015
Q3 | $29K | Buy |
271
+227
| +516% | +$28.2K | 0.01% | 270 |
|
|
2015
Q2 | $5K | Sell |
44
-200
| -82% | -$22.9K | ﹤0.01% | 450 |
|
|
2015
Q1 | $28K | Buy |
+244
| New | +$29.2K | 0.01% | 266 |
|
Other funds holding CELG
Allworth Financial's CELG Position: Q4 2019 in Review
Allworth Financial sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 100 shares — an estimated $10K sold.
Allworth Financial first reported a position in CELG in Q1 2015 and held it in 19 quarters. The position peaked at $52K in Q3 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Allworth Financial reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Allworth Financial sold 100 Celgene Corp shares in Q4 2019, an estimated $10K.
- Allworth Financial first reported a position in Celgene Corp in Q1 2015 and held it in 19 quarters.
- Allworth Financial's Celgene Corp position peaked at $52K in Q3 2017.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Allworth Financial's 13F filing for Q4 2019, filed 16 Jan 2020.